RNAi induced hepatotoxicity results from loss of the first synthesized isoform of miR-122 in mice

Small RNAs can be engineered to target and eliminate expression of disease-causing genes or infectious viruses, resulting in the preclinical and clinical development of RNA interference (RNAi) therapeutics using these small RNAs. To ensure the success of RNAi therapeutics, small hairpin RNAs (shRNAs) must co-opt sufficient quantities of the endogenous microRNA machinery to elicit efficient gene knockdown without impeding normal cellular function. We previously observed liver toxicity—including hepatocyte turnover, loss of gene repression and lethality—in mice receiving high doses of a recombinant adeno-associated virus (rAAV) vector expressing shRNAs (rAAV-shRNAs); however the mechanism by which toxicity ensues has not been elucidated. Using rAAV-shRNAs we have now determined that hepatotoxicity arises when exogenous shRNAs exceed 12% of the total amount of liver microRNAs. After this threshold was surpassed, shRNAs specifically reduced the initially synthesized 22-nucleotide isoform of microRNA (miR)-122-5p without substantially affecting other microRNAs, resulting in functional de-repression of miR-122 target mRNAs. Delivery of a rAAV-shRNA vector expressing mature miR-122-5p could circumvent toxicity, despite the exogenous shRNA accounting for 70% of microRNAs. Toxicity was also not observed in Mir122–knockout mice regardless of the level or sequence of the shRNA. Our study establishes limits to the microRNA machinery that is available for therapeutic siRNAs and suggests new paradigms for the role of miR-122 in liver homeostasis in mice.

[1]  Charles E. Vejnar,et al.  Integration of microRNA miR-122 in hepatic circadian gene expression. , 2009, Genes & development.

[2]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[3]  Michael T. McManus,et al.  Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis. , 2009, Gastroenterology.

[4]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[5]  B. Cullen,et al.  Derivation and characterization of Dicer- and microRNA-deficient human cells , 2014, RNA.

[6]  Stefan L Ameres,et al.  Long-term, efficient inhibition of microRNA function in mice using rAAV vectors , 2012, Nature Methods.

[7]  D. Tollervey,et al.  Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding , 2013, Cell.

[8]  C. Sander,et al.  miR-122, a Mammalian Liver-Specific microRNA, is Processed from hcr mRNA and MayDownregulate the High Affinity Cationic Amino Acid Transporter CAT-1 , 2004, RNA biology.

[9]  Frederik Graw,et al.  Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver. , 2013, Gastroenterology.

[10]  Praveen Sethupathy,et al.  Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C , 2015, Scientific Reports.

[11]  Kathleen A. Marshall,et al.  Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial , 2009, The Lancet.

[12]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[13]  Theresa A. Storm,et al.  Large-Scale Molecular Characterization of Adeno-Associated Virus Vector Integration in Mouse Liver , 2005, Journal of Virology.

[14]  A. Silahtaroglu,et al.  Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver , 2007, Nucleic acids research.

[15]  Theresa A. Storm,et al.  Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. , 2010, The Journal of clinical investigation.

[16]  M. Caligiuri,et al.  Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. , 2012, The Journal of clinical investigation.

[17]  V. Beneš,et al.  The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. , 2011, The Journal of clinical investigation.

[18]  J. Mendell,et al.  Gene Therapy for Duchenne Muscular Dystrophy: Expectations and Challenges , 2007 .

[19]  Hsien-Da Huang,et al.  MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. , 2012, The Journal of clinical investigation.

[20]  M. Kay,et al.  A mini-intronic plasmid (MIP): a novel robust transgene expression vector in vivo and in vitro. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  W. Filipowicz,et al.  Relief of microRNA-Mediated Translational Repression in Human Cells Subjected to Stress , 2006, Cell.

[22]  Jay Shendure,et al.  Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. , 2012, Molecular cell.

[23]  Martin Reczko,et al.  DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows , 2013, Nucleic Acids Res..

[24]  T. Katoh,et al.  Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. , 2009, Genes & development.

[25]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[26]  T. Tuschl,et al.  Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.

[27]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[28]  John E. Le Lay,et al.  Hepatic function is preserved in the absence of mature microRNAs , 2009, Hepatology.

[29]  Anjali J. Koppal,et al.  Supplementary data: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites , 2010 .

[30]  M. Kay.  State-of-the-art gene-based therapies: the road ahead , 2011, Nature Reviews Genetics.

[31]  K. Tsutsumi,et al.  Expression of aldolase isozyme mRNAs in fetal rat liver. , 1984, European journal of biochemistry.

[32]  Yue Zhang,et al.  The Loop Position of shRNAs and Pre-miRNAs Is Critical for the Accuracy of Dicer Processing In Vivo , 2012, Cell.

[33]  Anton J. Enright,et al.  SylArray: a web server for automated detection of miRNA effects from expression data , 2010, Bioinform..

[34]  Mark Graham,et al.  miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. , 2006, Cell metabolism.

[35]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[36]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[37]  N. Cross,et al.  Catalytic deficiency of human aldolase B in hereditary fructose intolerance caused by a common missense mutation , 1988, Cell.

[38]  A. Mele,et al.  Hepatitis C Virus RNA Functionally Sequesters miR-122 , 2015, Cell.

[39]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[40]  M. Longaker,et al.  Donor-Derived, Liver-Specific Protein Expression after Bone Marrow Transplantation , 2004, Transplantation.

[41]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[42]  John J Rossi,et al.  RNAi and small interfering RNAs in human disease therapeutic applications. , 2010, Trends in biotechnology.

[43]  Theresa A. Storm,et al.  Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways , 2006, Nature.

[44]  F. Hommes,et al.  The development of L- and M-type aldolases in rat liver. , 1970, Biochimica et biophysica acta.